Recent studies have shown that expression of the E-protein bHLH transcription factor, E2A/TCF3, that is one of the key targets of ID proteins, is elevated relative to normal B cell subsets in CLL and also promotes cell survival [45]; E2A mRNA knock-down leads to reduced CLL cell viability [45]. This evidence concerns the gene TCF3 and B-cell chronic lymphocytic leukemia.